I am a clinical cardiologist specializing in the comprehensive management of co-existing cardiovascular disease and cancer as well as the cardio-toxic side effects of chemotherapy treatment. Through close collaboration with the cancer treatment team, my goal is to ensure the best outcomes for patients with cancer who are at risk for or who have concurrent cardiovascular disease. I work closely with the oncologists to monitor patient’s cardiovascular health during treatment and provide long-term follow-up cardiac care for cancer survivors. I also provide cardiac evaluation for patients with cancer who are scheduled to undergo major surgery or to receive potentially cardio-toxic cancer treatment.
My clinical research focuses on providing earlier detection of cardio-toxic side effects of cancer treatment through the use of specialized cardiac imaging tests. I am dedicated to finding new ways to prevent, diagnose, and treat cardiac disease as a complication of cancer treatment.
- Clinical Expertise: Clinical cardiology; Echocardiography; Nuclear Cardiology
- Languages Spoken: English
- Education: MD, Harvard Medical School
- Residencies: Hospital of the University of Pennsylvania
- Fellowships: Mount Sinai Medical Center (New York)
- Board Certifications: Internal Medicine; Echocardiography
Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.
Clinical Trials Led by Anthony F. Yu
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more